Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial

NCT05405868 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

496

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma, Open-Angle

Interventions

DRUG: Nicotinomide
DRUG: Matching placebo

Sponsor

University College, London

Collaborators

[object Object]